Digoxin population pharmacokinetics from routine clinical data: role of patient characteristics for estimating dosing regimens.
about
Gender-related differences in pharmacokinetics and their clinical significance.Population pharmacokinetics I: background, concepts, and models.Population pharmacokinetics and optimization of the dosing regimen of digoxin in adult patientsA feasibility study of the multiple-peak approach for pharmacokinetic screening: population-based investigation of valproic acid relative clearance using routine clinical pharmacokinetic data.Pharmacokinetic and pharmacodynamic alterations in older people with dementia.Population pharmacokinetic investigation of digoxin in Japanese neonates.Impact of pharmacokinetics and pharmacogenetics on the efficacy of pranlukast in Japanese asthmatics.Pharmacoepidemiologic detection of calcium channel blocker-induced change on digoxin clearance using multiple trough screen analysis.Interaction between structural, statistical, and covariate models in population pharmacokinetic analysis.Determination of digoxin clearance in Japanese elderly patients for optimization of drug therapy: a population pharmacokinetics analysis using nonlinear mixed-effects modelling.Population-based investigation of relative clearance of digoxin in Japanese patients by multiple trough screen analysis: an update.Gender differences in pharmacokinetics of lumefantrine and its metabolite desbutyl-lumefantrine in rats.Predictive performance of four pharmacokinetic methods for calculating digoxin dosage.
P2860
Q33785861-1F9CAB6A-8647-4376-9668-C8CECBC963F7Q35870696-25FDC754-8A4A-49E3-82AC-ED7EA47C2B05Q36508024-EE163191-0D77-4310-8FA4-ECC42B523101Q36834098-A1DE798B-7109-4145-B7BF-C9AF90870CC0Q39275819-6B70D192-E7AD-460E-BE4D-E230AB10671AQ42626505-ECBCE1B5-57E9-4FBD-801A-88CFA272A14EQ43287061-2BE5CD11-0597-4F88-8168-D7108620F37FQ44062999-5F58D8A7-6975-4B8E-A7AE-BCF0772FE73CQ46119881-4EEB59CE-4124-49B2-93B0-8BC220C7C268Q46332430-3F6EFCF8-E378-4153-B240-EACC3C8EED2EQ50970492-B4F37E80-59FD-40CA-B32C-E9D653F68364Q51351015-D9CD6D6E-35C4-49F0-9ED2-D7704D1423C3Q52887073-D3D46BC8-911B-4967-AB6C-C9D405381D6A
P2860
Digoxin population pharmacokinetics from routine clinical data: role of patient characteristics for estimating dosing regimens.
description
1992 nî lūn-bûn
@nan
1992 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
name
Digoxin population pharmacokin ...... or estimating dosing regimens.
@ast
Digoxin population pharmacokin ...... or estimating dosing regimens.
@en
type
label
Digoxin population pharmacokin ...... or estimating dosing regimens.
@ast
Digoxin population pharmacokin ...... or estimating dosing regimens.
@en
prefLabel
Digoxin population pharmacokin ...... or estimating dosing regimens.
@ast
Digoxin population pharmacokin ...... or estimating dosing regimens.
@en
P2093
P2860
P921
P1476
Digoxin population pharmacokin ...... or estimating dosing regimens.
@en
P2093
P2860
P304
P356
10.1111/J.2042-7158.1992.TB05515.X
P577
1992-09-01T00:00:00Z